small business Grant Search

The following government grants in the FederalGrants.com database contain the term small business in the listing.

Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.

 

 

 

 
 
 Grant TitleCFDAFunding Number
Human Islet Research Network - Consortium on Targeting and Regeneration (HIRN-CTAR) (U01 Clinical Trial Not Allowed) 93.847 RFA-DK-22-009
HEAL Initiative: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy (MIRHIQL) (R01 Clinical Trial Required) 93.213, 93.242, 93.279, 93.393, 93.865, 93.866 RFA-DA-23-041
Point-of-Care Technologies Research Network: Technology Research and Development Centers (TRDC) (U54 Clinical Trial Optional) 93.213, 93.233, 93.279, 93.286, 93.394, 93.397, 93.398, 93.837, 93.838, 93.839, 93.855, 93.989 PAR-22-203
Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required) 93.350 RFA-TR-22-029
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) 93.233, 93.837, 93.838, 93.839, 93.840 PAR-22-189
Collaborative Research Using Biosamples from Type 1 Diabetes Clinical Studies (R01 - Clinical Trial Not Allowed) 93.847 RFA-DK-22-021
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) 93.233, 93.837, 93.838, 93.839, 93.840 PAR-22-192
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) 93.233, 93.837, 93.838, 93.839, 93.840 PAR-22-193
Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies (R01 Clinical Trial Not Allowed) 93.242, 93.853 RFA-MH-22-280
Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies (R21 Clinical Trial Not Allowed) 93.242, 93.853 RFA-MH-22-281
Miner Safety and Health Training Program - Western United States 93.262 RFA-OH-23-004
Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS) 93.073 RFA-DD-23-001
HEAL Initiative: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy (MIRHIQL): Resource Center (U24- Clinical Trial Optional) 93.213, 93.279, 93.865 RFA-DA-23-042
More Monitoring of Cognitive Change, Continued (M3C3) (U2C Clinical Trial Optional) 93.866 RFA-AG-23-021
BRAIN Initiative: Transformative Brain Non-invasive Imaging Technology Development (UG3/UH3 Clinical Trial Not Allowed) 93.173, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 RFA-EB-22-001
Extracellular RNA Sequencing Research Resource for the Accelerating Medicines Partnership Parkinsons Disease (AMPPD) (R24 - Clinical Trial Not Allowed) 93.279 RFA-NS-23-014
OSERS: OSEP: Rhonda Weiss National Technical Assistance Center to Improve State Capacity to Collect, Report, Analyze, and Use Accurate IDEA Data in Accessible Formats, Assistance Listing Number 84.373Q 84.373 ED-GRANTS-071222-001
Diplomatic Training in Economic and Commercial Statecraft 19.900 DOS-GEO-22-GR-016-070822
Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required) 93.121, 93.233, 93.350, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.866, 93.867 RFA-HL-23-017
Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) 93.242 PAR-22-169
Regenerative Medicine Innovation Projects (RMIP) Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed) 93.121, 93.233, 93.350, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.866, 93.867 RFA-HL-23-020
Regenerative Medicine Innovation Projects (RMIP) Investigator- Initiated Studies (Collaborative U01 Clinical Trial Not Allowed) 93.121, 93.173, 93.233, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.866, 93.867 RFA-HL-23-019
New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Coordinating Center (U24 - Clinical Trial Not Allowed) 93.172, 93.233, 93.307, 93.837, 93.838, 93.839, 93.840, 93.853 RFA-HL-23-016
Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) 93.866 PAR-22-213
New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Clinical/Community Field Centers (UG3/UH3 - Clinical Trial Not Allowed) 93.172, 93.233, 93.307, 93.837, 93.838, 93.839, 93.840, 93.853 RFA-HL-23-015
CCRP Initiative: Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early-Stage Development (UG3/UH3 Clinical Trial Not Allowed) 93.113, 93.279, 93.846, 93.853, 93.855, 93.867 PAR-22-209
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional) 93.866 RFA-AG-23-030
Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) 93.242 PAR-22-170
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional) 93.866 RFA-AG-23-029
HEAL Initiative: Rapidly Assessing the Public Health Impact of Emerging Opioid Threats (UG1 - Clinical Trial Not Allowed) 93.213, 93.273, 93.279 RFA-DA-23-045
Novel approaches to support therapeutic development in ultra-rare cancers 93.103 RFA-FD-23-008
Applied Regulatory Science Research to Understand Factors that Affect the Safety and Efficacy of Underrepresented Populations in Oncology Therapeutic Development (U01) Clinical Trial Optional 93.103 RFA-FD-23-006
Site Selection in Oncology Clinical Trials: Considerations for Selecting Sites in Limited Geographic Regions or Areas of Political Unrest, Limiting Inspection Capabilities (U13) Clinical Trial not allowed. 93.103 RFA-FD-23-007
Innovation Award: COVID-19 and Health Equity (U01) Clinical Trials Not Allowed 93.103 RFA-FD-23-009
OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed 93.103 RFA-FD-23-005
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01) Clinical Trials Required 93.103 RFA-FD-23-001
HEAL Initiative: Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On (RM1 - Clinical Trial Optional) 93.213, 93.273, 93.279 RFA-DA-23-046
Partnership Intermediary Agreement (PIA) with ERDC 12.630 W912HZ22PIA01
Impact of the Microbiome-Gut-Brain Axis on Alzheimer's Disease and Alzheimer's Disease-Related Dementias (R01 Clinical Trial Not Allowed) 93.853, 93.866 PAR-22-211
Claude D. Pepper Older Americans Independence Centers (P30 Clinical Trial Optional) 93.866 RFA-AG-23-017
Search Results 2081-2120 of 20969
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 [Next]

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com